Ilias Nikolakopoulos
@INikolakopoulos
Followers
479
Following
1K
Media
23
Statuses
539
#TCT2024: In #JACC, @KoshiroSakai_MD, @ziadalinyc, and team report that photon-counting CT imaging ⬆️ diagnostic performance for obstructive CAD compared with conventional CT https://t.co/2DQi3cL4Rk
#cvCAD #cvImaging #CardioX
2
36
108
Just 10 days left until our CT for PCI Course 2.0! We’re thrilled to host this event for the second time this year. 📅 October 24-25, 2024 | Minneapolis, MN Meet the Course Directors: @YaderSandoval @JoaoLCavalcante @Esbrilakis @ColletCarlos
@MHIF_Heart @SCAI #CT4PCI
0
15
36
The game just changed in cardiology! 🫀 Coronary CT #CCTA can now assess coronary microvascular dysfunction – a huge leap forward in diagnosing and treating microvascular disease. 🌟 This could reshape how we approach #CMD 🔥Just published @JACCJournals
7
62
236
We are thrilled to announce the @MHIF_Heart CT for PCI 2.0 course on Oct 24-25, 2024! 1.5 days of lectures & discussions, hands-on training, & live cases. Limited open registration: https://t.co/zeAMyEIWDf Join us to discuss & learn together about #CT4PCI @CCAD_MHIF @esbrilakis
1
15
55
Results of this cohort study show that large TET2 and ASXL1 CHIP—but not DNMT3A CHIP—were associated with higher IL-6 level, indices of cardiac remodeling, and an increased risk for AF. https://t.co/IBqfU0DNgl
0
8
18
Patients w/ #CCD who were younger or had a high burden of angina derived ⬆️ symptomatic benefit from invasive management Models to predict a patient's 1-yr health status outcomes w/ different Tx strategies could be used to inform shared decision-making https://t.co/5MjWSpNAba
0
11
28
Why does treating #TR improve dyspnoea? Find out more on the importance and effects of #TTEER on left 🫀 #hemodynamics and #HeartFailure
https://t.co/zgKQx2Lxod
@kp_rommel @PhilippLurz @thiele_holger @A_Schoeber @RoschSeb @PSullivan000 @MarcoMetra @FH_Verbrugge a 🧵1/6
onlinelibrary.wiley.com
Aims The aim of this study was to assess the pathophysiological implications of severe tricuspid regurgitation (TR) in patients with heart failure with preserved ejection fraction (HFpEF) by using...
2
27
68
To screen or not to screen for #ASCVD with cancer treatment? Historic #ACC24 moments with phenomenal cases and debates on all questions #CardioOnc. Kudos @GiselleSA_MDPhD @DrTochiOkwuosa @datsunian @onco_cardiology
0
7
25
Over the last three days, we’ve seen almost all pharmacological strategies presented at #ACC24 fail, including beta blockers, which seemed like the only certainty. On the contrary, if we are to believe in the results we've seen, we should start using more microaxial flow pump
11
53
224
Couldn’t be prouder of @MikeFoley89 and the ORBITA team today. What are the chances that ORBITA-COSMIC would be published on the same day as a solar eclipse?!
7
18
218
After 10 years to complete it, the DanGer-SHOCK trial showed that the routine use of a microaxial flow pump with standard care in the treatment of patients with STEMI-related cardiogenic shock led to a lower risk of death from any cause at 180 days than standard care alone. The
12
93
276
The PREVENT trial showed that preventive #PCI of focal non-FFR-positive plaques that are angiographically >50% & have evidence of vulnerability on intravascular imaging along w/ OMT is superior to OMT for clinical outcomes at 2 years. Read more: https://t.co/vmsq7FRdYH
#ACC24
11
140
340
Amazing to see a brilliant friend and colleague @MikeFoley89 present the #ORBITA-COSMIC trial of the coronary sinus reducer with simultaneous publication in @TheLancet @rallamee @ImperialNHLI @ImperialNHS #ACC2024
https://t.co/zzFSIYlhbz
1
14
69
Does age impact the optimal testing strategy for stable patients with suspected CAD? @YaleIMed star @evivemmou presenting her work from PRECISE!
0
3
41
I’m honored to join this amazing team! Look forward to contributing the advancement of this field☺️ @MHIF_Heart @GilbertTangMD @DeeDeeWangMD @TheLADoctor @SyedZaidMD
JUST IN! Proud to have an A++ ⭐️⭐️⭐️⭐️⭐️ #JACCCaseReports @JACCJournals Ed Board team: 2 🚺Deputy Editors, 16 Associate Editors >60% 🚺, diverse background, expertise, 🌎, carrier stages. 1st time w/ allied health & @VeteransHealth rep. Congrats & look fwd to an amazing 5y!
4
4
30
@ThinkingCC @KrKrramanathan @msiuba @ross_prager @IM_Crit_ @GraemeMacLaren @iamritu @ABCDEcografia @HoosierPocus @khaycock2 @NephroP 7/ 🔆 How to treat RVOTO? ♦️ Detect EARLY !! ♦️ Mechanical causes: - Surgery ♦️Dynamic causes: - Adequate preload - Inotropes withdrawal - Beta-blockers or CCBs
1
5
8
New @cards_lab #echofirst paper out in @JAMACardio #ACC24 We build on our recent work on detecting AS from 2D echo w/o Doppler using a video-based AI biomarker (DASSi, ref: https://t.co/o7XwUrFSSw) ✅DASSi stratifies the risk of AS progression among more than 12k participants
academic.oup.com
AbstractBackground and Aims. Early diagnosis of aortic stenosis (AS) is critical to prevent morbidity and mortality but requires skilled examination with D
A new #AI video biomarker is independently associated with aortic stenosis progression enabling opportunistic risk stratification across cardiovascular imaging modalities and handheld devices. https://t.co/LsyKdAkgZu
@cards_lab @rohan_khera @ekoikonomou @YaleCardiology #ACC24
2
15
76
Thank you for joining us at @MHIF_Heart for the 1st US meeting on CT-guided PCI! We had an incredible 1.5 days with outstanding lectures, hands-on sessions, & live cases addressing #CT4PCI. Huge thanks to our faculty speakers, participants, & sponsors for making this event a
6
16
82
Here we go again! Want to see if the coronary sinus reducer works in refractory angina? Watch @MikeFoley89 present the results of the ORBITA-COSMIC in the main arena at #ACC this Monday #ORBITA @fiyyazAJ @mshunshin @ShaynaChotai @rajkumar_chris @FloSimader
4
39
163